Compile Data Set for Download or QSAR
Report error Found 147 Enz. Inhib. hit(s) with all data for entry = 50030560
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298134((4S)5-Oxo-5-{4-[(pentyloxy)carbonyl]piperazin-1-yl...)
Affinity DataIC50: 550nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298135((4S)4-[({4-[4-(Aminomethyl)piperidin-1-yl]-6-pheny...)
Affinity DataIC50: 770nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298136((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 1.10E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298137((S)-4-(4-(4-(aminomethyl)piperidin-1-yl)-6-phenylp...)
Affinity DataIC50: 1.60E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298132((4S)4-[({4-[4-(Methoxymethyl)piperidin-1-yl]-6-phe...)
Affinity DataIC50: 1.80E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298138((S)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 1.90E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298179((4S)5-[4-(Ethoxycarbonyl)piperazin-1-yl]-5-oxo-4-(...)
Affinity DataIC50: 2.00E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298180((S)-4-(4-(4-(2-(dimethylamino)ethyl)piperazin-1-yl...)
Affinity DataIC50: 2.30E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298139((S)-4-(4-(4-hydroxypiperidin-1-yl)-6-phenylpicolin...)
Affinity DataIC50: 2.40E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298178((S)-4-(4-(4-aminopiperidin-1-yl)-6-phenylpicolinam...)
Affinity DataIC50: 2.80E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298140((4S)-4-(4-(1-(diethylamino)-1-oxobutan-2-yloxy)-6-...)
Affinity DataIC50: 3.00E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298141((S)-4-(4-(4-(aminomethyl)piperidin-1-yl)-6-phenylp...)
Affinity DataIC50: 3.30E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298115((S)-4-(4-(3-aminopropoxy)-6-phenylpicolinamido)-5-...)
Affinity DataIC50: 3.80E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298132((4S)4-[({4-[4-(Methoxymethyl)piperidin-1-yl]-6-phe...)
Affinity DataIC50: 3.90E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298142((S)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 4.00E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298143((S)-4-(4-(methyl(2-(methylsulfonyl)ethyl)amino)-6-...)
Affinity DataIC50: 4.10E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298144((4S)4-({[4-(2-Methoxyethoxy)6-phenylpyridin-2-yl]c...)
Affinity DataIC50: 4.30E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298145((4S)5-[4-(Butoxycarbonyl)iperazin-1-yl]-4-({[4-(2-...)
Affinity DataIC50: 4.40E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298146((S)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-4-(4-(2-m...)
Affinity DataIC50: 5.80E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298147((S)-5-(4-(hexyloxycarbonyl)piperazin-1-yl)-4-(4-(4...)
Affinity DataIC50: 6.40E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298117((4S)4-({[4-(2-Aminoethoxy)6-phenylpyridin-2-yl]car...)
Affinity DataIC50: 7.50E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298149((4S)5-[4-(Ethoxycarbonyl)iperazin-1-yl]-4-({[4-(2-...)
Affinity DataIC50: 7.60E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298150((S)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-4-(4-(met...)
Affinity DataIC50: 7.60E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298151((S)-5-(4-(hexyloxycarbonyl)piperazin-1-yl)-4-(4-(4...)
Affinity DataIC50: 7.60E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298152((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(4-(2-h...)
Affinity DataIC50: 7.80E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298153((S)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-4-(4-(2-h...)
Affinity DataIC50: 8.10E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298154((S)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 8.50E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298155((4S)5-[4-(Ethoxycarbonyl)iperazin-1-yl]-4-({[4-(3-...)
Affinity DataIC50: 9.00E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298156((S)-5-(4-(allyloxycarbonyl)piperazin-1-yl)-5-oxo-4...)
Affinity DataIC50: 9.40E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298157((4S)5-[4-(Ethoxycarbonyl)piperazin-1-yl]-4-({[4-(4...)
Affinity DataIC50: 9.80E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298158((4S)5-[4-(Ethoxycarbonyl)piperazin-1-yl]-4-[({4-[4...)
Affinity DataIC50: 9.90E+3nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298113((S)-5-(4-(allyloxycarbonyl)piperazin-1-yl)-4-(4-(2...)
Affinity DataIC50: 1.11E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298160((4S)4-({[4-(2-Hydroxyethoxy)6-phenylpyridin-2-yl]c...)
Affinity DataIC50: 1.15E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298170((S)-5-(4-(allyloxycarbonyl)piperazin-1-yl)-4-(4-(2...)
Affinity DataIC50: 1.33E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298172((S)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-4-(4-(2-m...)
Affinity DataIC50: 1.40E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298166((S)-4-(4-(4-(aminomethyl)piperidin-1-yl)-6-phenylp...)
Affinity DataIC50: 1.41E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298159((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50: 1.50E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298168((S)-5-(4-((2-cyclopentylethoxy)carbonyl)piperazin-...)
Affinity DataIC50: 1.75E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298181((S)-4-(4-(methyl(2-(methylsulfonyl)ethyl)amino)-6-...)
Affinity DataIC50: 1.77E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298182((S)-5-(4-(hexyloxycarbonyl)piperazin-1-yl)-5-oxo-4...)
Affinity DataIC50: 1.90E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298177((S)-5-(4-(isopropoxycarbonyl)piperazin-1-yl)-4-(4-...)
Affinity DataIC50: 2.01E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298120((S)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 2.10E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298174((S)-4-(4-(2-hydroxyethoxy)-6-phenylpicolinamido)-5...)
Affinity DataIC50: 2.56E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298183((4S)5-[4-(Butoxycarbonyl)iperazin-1-yl]-4-{[(4-but...)
Affinity DataIC50: 2.69E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298185((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 2.80E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298165((S)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50: 2.80E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298161((4S)4-{[(4-Butoxy-6-phenylpyridin-2-yl)carbonyl]am...)
Affinity DataIC50: 2.84E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298184((S)-4-(4-(benzyloxy)-6-phenylpicolinamido)-5-(4-(e...)
Affinity DataIC50: 3.10E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298186((4S)4-{[(4-Butoxy-6-phenylpyridin-2-yl)carbonyl]am...)
Affinity DataIC50: 3.39E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetP2Y purinoceptor 12(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50298116((S)-4-(4-(2-(dimethylamino)ethylamino)-6-phenylpic...)
Affinity DataIC50: 3.60E+4nMAssay Description:Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
Displayed 1 to 50 (of 147 total ) | Next | Last >>
Jump to: